title: HDAC inhibition: A novel therapeutic target for pulmonary hypertension by reducing right ventricular hypertrophy through diverse pathological mechanisms.
authors.affiliation: Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
authors.forename: Yi-Yuan
authors.initials: YY
authors.lastname: Huang
authors.affiliation: Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China. Electronic address: zhenfeifang0829@gmail.com.
authors.forename: Zhen-Fei
authors.initials: ZF
authors.lastname: Fang
authors.affiliation: Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
authors.forename: Xin-Qu
authors.initials: XQ
authors.lastname: Hu
authors.affiliation: Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
authors.forename: Sheng-Hua
authors.initials: SH
authors.lastname: Zhou
mesh_terms: D016503:Drug Delivery Systems; D056572:Histone Deacetylase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D017202:Myocardial Ischemia / Q000517:prevention & control*; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D020257:Ventricular Remodeling / Q000187:drug effects*
chemical_list: D056572:Histone Deacetylase Inhibitors
keywords: Histone deacetylases(HDACs); Pulmonary hypertension; Right ventricular hypertrophy